Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2001036978) METHODS FOR PRODUCING, OPTIMIZING, AND MONITORING THE QUALITY OF CELLULAR VACCINES
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/036978 International Application No.: PCT/US2000/042213
Publication Date: 25.05.2001 International Filing Date: 15.11.2000
Chapter 2 Demand Filed: 12.06.2001
IPC:
G01N 33/50 (2006.01)
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Applicants:
SCHULTZE, Joachim, L. [DE/US]; US (UsOnly)
VONDERHEIDE, Robert, H. [US/US]; US (UsOnly)
NADLER, Lee, M. [US/US]; US (UsOnly)
MAECKER, Britta [DE/US]; US (UsOnly)
VON BERGWELT-BAILDON, Michael [DE/US]; US (UsOnly)
DANA-FARBER CANCER INSTITUTE, INC. [US/US]; 44 Binney Street Boston, MA 02115, US (AllExceptUS)
Inventors:
SCHULTZE, Joachim, L.; US
VONDERHEIDE, Robert, H.; US
NADLER, Lee, M.; US
MAECKER, Britta; US
VON BERGWELT-BAILDON, Michael; US
Agent:
CLARK, Paul, T.; Clark & Elbing LLP 176 Federal Street Boston, MA 02110-2214, US
Priority Data:
60/165,42815.11.1999US
Title (EN) METHODS FOR PRODUCING, OPTIMIZING, AND MONITORING THE QUALITY OF CELLULAR VACCINES
(FR) VACCINS CELLULAIRES : TECHNIQUES DE PRODUCTION, D'OPTIMISATION ET DE CONTROLE DE LA QUALITE
Abstract:
(EN) The invention provides methods for directly determining the density of major histocompatibility complex molecules and MHC/peptide complexes on the surfaces of antigen presenting cells. The invention also provid kits that can be used in carrying out the methods of the invention.
(FR) Cette invention concerne des techniques permettant de déterminer directement la densité de molécules à complexe majeur d'histocompatibilité (CMH) et de complexes CMH/peptides sur les surfaces de cellules présentatrices d'antigènes. Sont également décrites des kits permettant la mise en oeuvre de ces techniques.
Designated States: CA, JP, US
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
Publication Language: English (EN)
Filing Language: English (EN)